The regulatory effects of clomiphene and tamoxifen on mTOR and LC3-II expressions in relation to autophagy in experimental polycystic ovary syndrome (PCOS)-Reference-Cited by-同舟云学术

The regulatory effects of clomiphene and tamoxifen on mTOR and LC3-II expressions in relation to autophagy in experimental polycystic ovary syndrome (PCOS)

Published:2021-11-23 Issue: Volume: Page:
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Kuşçu Gökçe Ceren^ORCID,Gürel Çevik^ORCID,Buhur Aylin^ORCID,Oltulu Fatih^ORCID,Akman Levent^ORCID,Köse Timur^ORCID,Yavaşoğlu Nefise Ülkü Karabay^ORCID,Yavaşoğlu Altuğ^ORCID

Funder

Ege Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-021-06981-y.pdf

Reference50 articles.

1. Patil K, Yelamanchi S, Kumar M et al (2019) Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome. PLoS ONE 14:e0214742. https://doi.org/10.1371/journal.pone.0214742

2. Kobayashi M, Yoshino O, Nakashima A et al (2020) Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome. Mol Cell Endocrinol. https://doi.org/10.1016/j.mce.2020.110792

3. Costello MF, Misso ML, Balen A et al (2019) Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Hum Reprod Open. https://doi.org/10.1093/hropen/hoy021